Investigation of availability of solifenacin succinate on effect insufficiency cases by b3 receptor agonist -Switching study from mirabegron to solifenacin-

Trial Profile

Investigation of availability of solifenacin succinate on effect insufficiency cases by b3 receptor agonist -Switching study from mirabegron to solifenacin-

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2016

At a glance

  • Drugs Solifenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms WATCH
  • Most Recent Events

    • 16 Sep 2016 Results (n=27) presented at the 46th Annual Meeting of the International Continence Society
    • 11 Apr 2016 Status changed from active, no longer recruiting to completed.
    • 02 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top